Edition:
United Kingdom

Trevena Inc (TRVN.OQ)

TRVN.OQ on NASDAQ Stock Exchange Global Select Market

1.73USD
20 Apr 2018
Change (% chg)

$-0.02 (-1.14%)
Prev Close
$1.75
Open
$1.75
Day's High
$1.75
Day's Low
$1.72
Volume
91,121
Avg. Vol
189,657
52-wk High
$3.63
52-wk Low
$1.35

Select another date:

Thu, Apr 12 2018

BRIEF-Trevena Says Chief Financial Officer Roberto Cuca Will Resign, Effective May 3, 2018

* TREVENA SAYS ON APRIL 9, ROBERTO CUCA, CHIEF FINANCIAL OFFICER OF CO FORMALLY NOTIFIED CO OF HIS RESIGNATION, EFFECTIVE AS OF MAY 3, 2018 - SEC FILING Source text: (https://bit.ly/2GVszsP) Further company coverage:

BRIEF-Trevena Reports Q4 Loss Per Share $0.24

* COMPANY EXPECTS THAT EXPENSES WILL DECREASE IN 2018 COMPARED TO 2017

BRIEF-Trevena Inc Says FDA Indicated To Co That PDUFA Date For Olinvo NDA Is Nov 2‍​

* TREVENA INC - ON JAN 5, FDA INDICATED TO THE CO THAT PDUFA REVIEW DATE FOR OLINVO NDA IS NOV 2‍​

BRIEF-Trevena Announces FDA Acceptance For Review Of New Drug Application For OLINVO(Oliceridine) Injection

* TREVENA ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF NEW DRUG APPLICATION FOR OLINVO (OLICERIDINE) INJECTION

BRIEF-Trevena Inc says Q3 loss per share $0.27

* Trevena reports third quarter 2017 financial results and announces new positive clinical trial data

BRIEF-Trevena announces submission of NDA to U.S. FDA for Olinvo

* Trevena announces submission of new drug application to U.S. FDA for Olinvo (oliceridine injection)

BRIEF-‍trevena announces publication and presentations of olinvo clinical data​

* ‍Trevena announces publication and presentations of olinvo (oliceridine injection) clinical data​ Source text for Eikon: Further company coverage:

Select another date: